McKenzie, Patti, Heather, Jeannine, Yvonne & Anne's Training Site
Dr. Timothy L. Vollmer


Program Director,
BNI Neuroimmunology Program

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
My Educational Video on MS and MS Trials
Produced by www.MDhealthChannel.com
This site is Private and is used only for training new Angel Editors, Bloggers & Columnists!
Visitors..Plus 221,000 on MySpace
Click here to go to our MySpace Page
HERE'S A FEW OF OUR 3,200 MySpace FRIENDS
CLICKING ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
PLUS: Plus...we will notify you when we produce videos like the one below that we filmed last year...with Dr. Timothy Vollmer to help you understand Tysabri's withdrawal from the market
Timothy L. Vollmer M.D.
Program Director, BNI Neuroimmunology Program
Barrow Neurological Institute
St. Joseph's Hospital and Medical Center


BARROW NEUROLOGICAL INSTITUTE'S
GRAND CANYON
RIM-RIM-HIKE


Organized by Dr. Robert F. Spetzler - Director, Barrow Neurological Institute

250 Photo-Slideshow


Click to view 1280 MS Walk photos!

"Join a trial at Barrow & receive all medication & study based procedures at no charge!"
Stan Swartz, CEO, The MD Health Channel

"WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!"
Simply click the "video" buttons below:

.

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

"OUR TEAM IS WORKING ON A CURE FOR MS"
Runtime: 54 sec
Runtime: 54 sec
Susan N. Rhodes
Multiple Sclerosis Research
Barrow Neurological Institute

"'The 2006 Barrow Neurological Institute at St. Joseph's Hospital MS "Walk on the Wild Side" raised more than $460,000 with 3,500 walkers! Click on the blue link above to view photos"

Chris Uithoven
President
National Multiple Sclerosis Society
Arizona Chapter


"THE MS SOCIETY OFFERS MANY PROGRAMS TO HELP...EVERYTHING FROM PILATES & SUPPORT GROUPS TO HORSEBACK RIDING"
Jerry Turner
Program Director
National Multiple Sclerosis Society
Arizona Chapter

Previious Posts

MS NEWS ARCHIVES: by week
January 2007  
November 2007  
April 2008  
July 2008  
December 2008  
January 2009  
February 2009  
March 2009  
March 2010  
April 2010  
May 2010  
August 2010  
May 2013  
June 2013  
July 2013  
January 2014  
February 2014  
March 2014  
April 2014  

This page is powered by Blogger. Isn't yours?

1/22/14

 
Researchers from the University of Alabama at Birmingham (UAB) have discovered a new immune protein influencing autoimmune diseases such as lupus and multiple sclerosis.
In autoimmune diseases like lupus, the body's immune system overreacts and attacks healthy tissue, instead of just eliminating germs. Lupus can affect lots of different areas of the body including the joints, skin, kidneys, lungs, heart and the brain. The symptoms of lupus vary from person to person and can include fever, kidney trouble, feeling tired all the time and rashes. Because the effects of the disease vary so much from patient to patient, it is important to develop personalized therapies to provide people with treatment that is right for them. The researchers behind the new study think a new mutation of an immune protein called an "Fc receptor" may help scientists develop more personalized autoimmune disease treatments. The Fc receptor regulates the production of antibodies that attack bacteria in our bodies. Previously, scientists thought that Fc receptors could only shut down antibody production, but about 15% of the world's population have this new kind of Fc receptor that can also activate antibody production. In people with lupus, this means that the Fc receptor would create too many antibodies, resulting in an attack on healthy cells. Being able to identify this receptor mutation in patients could help doctors prescribe treatments specific to that patient, and it could also provide early warning signs of autoimmune disease. Fc receptors as personalized treatment and screening tool Dr. Robert Kimberly, director of the UAB Center for Clinical and Translational Science, who co-authored the paper, says: "This new finding could play a significant role in the way companies design treatments for autoimmune diseases, in a more targeted approach. Now efforts can be made to target the individuals who will benefit from the treatments, based on the gene mutation." The efficacy of treatments for autoimmune disease is often determined by the genes that "fine-tune" the immune system of an individual. Dr. Kimberley and his team believe that identifying this new gene in patients will not only lead to faster, more appropriate treatment for patients, but will also potentially save time and money for the pharmaceutical industry.
READ MORE

Comments:

Post a Comment



<< Home